SRC and type 2 diabetes mellitus: SRC is currently being directly evaluated in Phase II clinical trials in patients with type 2 diabetes and chronic kidney disease (www.prokidney.com) This trial is built on the success of a Phase I clinical trial of 7 type II diabetic patients with CKD3/4.